Erasca, Inc. Share Price
NASDAQ: ERAS | Mid CapErasca, Inc. Stock Performance
Erasca, Inc. Share Price Today
As of 30 October 2026, Erasca, Inc.'s share price is $14.99. The stock opened at $15.03, compared to its previous close of $15.12. During today's trading session, Erasca, Inc.'s share price traded between $14.66 and $15.40, with an average price of $15.03. Over the past 52 weeks, the stock has recorded a high of $24.28 and a low of $2.10. In terms of performance, Erasca, Inc.'s share price has risen by 40.88% over the last six months and is up 519.42% on a year-on-year basis.
Erasca, Inc. Share Price Chart
Erasca, Inc. Quarterly Profit & Loss
All figures in USD
Erasca, Inc. Annual Profit & Loss
All figures in USD
About Erasca, Inc.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Its focused RAS/MAPK pathway pipeline comprises modality-agnostic programs aligned with three therapeutic strategies of: targeting key upstream and downstream signaling nodes in the RAS/MAPK pathway; targeting RAS directly; and targeting escape routes that emerge in response to treatment. Its pipeline includes two clinical-stage programs (ERAS-0015, a pan-RAS molecular glue; and ERAS-4001, a pan-KRAS inhibitor), and ERAS-12, a discovery-stage program.
Erasca, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $14.53 | $15.02 | +2.04% |
Sep 2026 | $17.64 | $14.71 | -24.56% |
Aug 2026 | $17.17 | $19.50 | +7.52% |
Jul 2026 | $18.00 | $18.14 | -1.14% |
Jun 2026 | $13.17 | $18.35 | +42.91% |
May 2026 | $10.39 | $12.84 | +20.68% |
Apr 2026 | $16.36 | $10.64 | -34.20% |
Mar 2026 | $13.58 | $16.17 | +18.37% |
Feb 2026 | $10.51 | $13.66 | +29.72% |
Jan 2026 | $3.71 | $10.53 | +182.31% |
Dec 2025 | $3.17 | $3.73 | +17.30% |
Nov 2025 | $2.40 | $3.18 | +31.40% |